N.C. Blues Plan Strives for Positive Pharmacy Experience
As Medicare Advantage organizations prepare for patient experience and access measures to take on a larger weight starting with the 2023 Medicare Parts C and D star ratings, MA Prescription Drug (MA-PD) plan sponsors should pay particular attention to customers’ pharmacy experience. Although there are only two Part D measures based on the annual Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey — Rating of Drug Plan and Getting Needed Prescription Drugs, which will both move from a weight of 2 to 4 — a patients’ overall experience can be heavily influenced by their ability to obtain a prescription drug. That’s why Blue Cross Blue Shield of North Carolina has taken a multidisciplinary approach to assessing member experience and how it can be affected by the pharmacy benefit.
Related Posts

Operationalizing MA Supplemental Benefits, Network Adequacy Proposals Could Impact Stars
READ MORE
News Briefs: Suit Accuses UnitedHealth of Using AI to Wrongfully Deny MA Care
READ MORE